M. Witt

Targeting JAK kinase in solid tumors: emerging opportunities and challenges

Therapeutic opportunities of the IL-22–IL-22R1 system

The IL-23–IL-17 axis in inflammatory arthritis

Inflammation and tumor progression: signaling pathways and targeted intervention

The JAK/STAT signaling pathway: from bench to clinic

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Hidradenitis suppurativa

Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases

Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis

Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis

Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations